Percutaneous cryoablation of abdominal wall endometriosis: An analysis of 38 patients - 01/09/24
, Nithida Sengmanivong a, Fabien Vidal b, Céline Goumarre a, Franck Lapègue a, Louise Destombes a, Hélène Chiavassa Gandois a, Yann Tanguy Le Gac c, Elodie Chantalat d, Jérome Capdet e, Donatien Blais e, Adrien Guenego f, Nicolas Sans a, Marie Faruch Bilfeld aHighlights |
• | Percutaneous cryoablation is an effective, minimally invasive intervention for the treatment of abdominal wall endometriosis. |
• | Percutaneous cryoablation results in effective pain relief in 82% of women with abdominal wall endometriosis. |
• | Percutaneous cryoablation conveys minimal or no morbidity and has no esthetic consequences in young women with abdominal wall endometriosis. |
Abstract |
Purpose |
The purpose of this study was to evaluate the efficacy of percutaneous cryoablation in the treatment of abdominal wall endometriosis (AWE) nodules.
Materials and methods |
Thirty-eight women treated for symptomatic AWE nodules with percutaneous cryoablation under ultrasound and computed tomography (CT) guidance between May 2020 and July 2023 were retrospectively included. Pain was estimated using visual analog scale (VAS) and assessed at baseline, three months, six months, and 12 months after percutaneous cryoablation. Baseline VAS score, volume of AWE nodule and magnetic resonance imaging (MRI) features of AWE nodules were compared to those obtained after percutaneous cryoablation. Major complications, if any, were noted.
Results |
Thirty-eight women with a median age of 35.5 years (interquartile range [IQR]: 32, 39; range: 24–48 years) and a total of 60 AWE nodules were treated. Percutaneous cryoablation was performed under local or regional anesthesia in 30 women (30/38; 79%). Significant decreases between initial median VAS score (7; IQR: 6, 8; range: 3–10) and median VAS score after treatment at three months (0; IQR: 0, 5; range; 0–8) (P < 0.001), six months (0; IQR: 0, 1; range; 0–10) (P < 0.001) and 12 months (0; IQR: 0, 2; range: 0–7) (P < 0.001) were observed. Percutaneous cryoablation resulted in effective pain relief in 31 out of 38 women (82%) at six months and 15 out of 18 women (83%) at 12 months. Contrast-enhanced MRI at six-month follow-up showed a significant decrease in the volume of AWE nodules and the absence of AWE nodule enhancement after treatment by comparison with baseline MRI (P < 0.001). No major complications were reported.
Conclusion |
Percutaneous cryoablation is an effective, minimally invasive intervention for the treatment of AWE nodules that conveys minimal or no morbidity.
Le texte complet de cet article est disponible en PDF.Keywords : Abdominal wall endometriosis, Cryoablation, Cryosurgery, Pain, Visual analog scale
Abbreviations : AWE, CT, IQR, MRI, VAS
Plan
Vol 105 - N° 9
P. 319-325 - septembre 2024 Retour au numéro
Article précédent
- Comparison of low-energy virtual monoenergetic images between photon-counting CT and energy-integrating detectors CT: A phantom study
- Joël Greffier, Sebastian Faby, Maxime Pastor, Julien Frandon, Julien Erath, Jean Paul Beregi, Djamel Dabli
- Side branch embolization before endovascular abdominal aortic aneurysm repair to prevent type II endoleak: A prospective multicenter study
- Tomoyuki Gentsu, Masato Yamaguchi, Koji Sasaki, Ryota Kawasaki, Hiroki Horinouchi, Tetsuya Fukuda, Naokazu Miyamoto, Takeki Mori, Noriaki Sakamoto, Kensuke Uotani, Takanori Taniguchi, Yojiro Koda, Katsuhiro Yamanaka, Hiroaki Takahashi, Kenji Okada, Taro Hayashi, Toshitaka Watanabe, Yoshikatsu Nomura, Keigo Matsushiro, Eisuke Ueshima, Takuya Okada, Koji Sugimoto, Takamichi Murakami
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?